Niagen Bioscience, Inc. (NAGE)
Who owns Niagen Bioscience, Inc. (NAGE)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 74.8% of the shares are freely tradable; institutional investors hold 47.2%.
Ownership Structure
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 4.86 | 3,871,619 | -5.0 | 03/31/2026 |
| Steel Peak Wealth Management LLC | 4.24 | 3,373,000 | +0.0 | 03/31/2026 |
| Vanguard Group Inc | 4.13 | 3,286,498 | -18.3 | 12/31/2025 |
| Arrowstreet Capital Limited Partnership | 2.99 | 2,378,437 | +47.1 | 03/31/2026 |
| Vanguard Capital Management, LLC | 2.70 | 2,149,277 | +0.0 | 03/31/2026 |
| Tieton Capital Management, LLC | 2.55 | 2,029,155 | +23.3 | 03/31/2026 |
| Qube Research & Technologies | 2.15 | 1,714,639 | +61.5 | 03/31/2026 |
| UBS Group AG | 1.76 | 1,405,531 | -0.4 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Tieton Small Cap Value | 2.55 | 2,029,155 | +23.3 | 03/31/2026 |
| Vanguard Total Stock Mkt Idx Inv | 1.85 | 1,470,818 | +0.0 | 04/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 30. Jun 2026 | Lopez Carlos Luis | SVP, General Counsel | Other | 2,314 | 2.71 | 6,271 |
| 30. Jun 2026 | Pamir Ozan | Chief Financial Officer | Other | 4,255 | 2.71 | 11,531 |
| 30. Jun 2026 | Fried Robert N | Chief Executive Officer | Other | 1,106 | 2.71 | 2,997 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.